Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04832503
Other study ID # RF-2016-02361560
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 30, 2018
Est. completion date March 30, 2023

Study information

Verified date October 2023
Source IRCCS Fondazione Stella Maris
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Childhood Apraxia of Speech (CAS) is a severe speech-language disorder whose aetiological, neuroanatomical correlates are largely unknown. Furthermore, little is known about the neuroplastic effects induced by different treatment approaches and their relationships with the potential changes in the speech behavioural features that express the core deficit of CAS. Twenty four children with idiopathic CAS will be enrolled in a multidisciplinary study aimed at analysing the behavioural and neuroanatomical effects of a specific rehabilitative approach, PROMPT (PROMPTs for Restructuring Oral Muscular Phonetic Targets), that employs tactile-kinesthetic-proprioceptive cues vs a traditional speech-language treatment. The children will be allocated in two arms, one receiving a seven month cycle of individual PROMPT treatment, the other a traditional speech and language treatment for the same amount of time.The pre- and post-treatment speech and language performances and DTI and volumetric MR data will be compared in the two groups.


Description:

Background: Childhood Apraxia of Speech (CAS) is a severe speech-language disorder whose etiological, neuroanatomical and genetic correlates are largely unknown. In this trial the effects of an innovative rehabilitative approach, PROMPT (PROMPTS for Restructuring Oral Muscular Phonetic Targets) will be evaluated from a behavioral and neuroanatomical point of view. Objective: the current study is aimed to assess speech-language and white matter microstructure and volumetric changes induced by the PROMPT treatment. Participants: Twenty-two Children with CAS aged 4 -12 years are enrolled and assigned to a PROMPT treatment (PROMPT-t ) or a Language and Non-Speech Oral Motor-treatment group (LNSOM-t). Methods: All children with CAS will undergo a comprehensive clinical, neurological and speech-language assessment. The following procedures will be applied: a) anamnestic interview b) oral non verbal and verbal movements eveluation c) phonetic inventory, accuracy and consistency of speech d) DDK (Diadochokinetic rate, receptive and expressive vocabulary and grammar tests; f) spontaneous language analysis. These multiple measurements were aggregated and converted into a speech and language composite score. MRI data will be acquired using a 1.5 T MR scanner. Structural images obtained with a 3D isotropic T1 weighted sequence will be analysed to evaluate volumetric alterations, to investigate cortical thickness and automatically delineate various Regions of Interest (ROIs). HARDI images will be acquired using 32 gradient directions and will be processed using tools available in FSL and MRtrix. Tract-based spatial statistics (TBSS) will be used to statistically analyse images of FA and mean diffusivity. Fiber tracts will be calculated using constrained spherical deconvolution and probabilistic tractography. Connectomes will be calculated by combining ROIs obtained from the structural images with tractography. Network-based analysis will be used to statistically analyse connectomes. Speech and language assessment and brain MRI VBM and DTI analysis will be performed at baseline and at the end of the treatment. Statistical analysis: Paired t-test on pre and post treatment behavioural and MRI/DTI measures will be performed to assess the changes within each of the two groups. Moreover, comparisons between the two groups at T0 and T1 will be performed by means of non parametric tests. Evaluation of potentially training-induced changes of brain structural connectivity may provide further support to the hypothesis that CAS is due to a disruption of networks subserving the speech production system.


Recruitment information / eligibility

Status Completed
Enrollment 24
Est. completion date March 30, 2023
Est. primary completion date January 30, 2023
Accepts healthy volunteers
Gender All
Age group 4 Years to 16 Years
Eligibility Inclusion Criteria: - Diagnosis of idiopathic CAS based on the presence of specific diagnostic features of apraxia of speech (see ASHA and Strand et al's criteria) and on a comprehensive clinical and neurological assessment. - Non-verbal IQ within the normal range at standardized tests of intelligence. - Normal structural brain MRI. - Acquisition of parents' informed consent to the execution of behavoiural and neuroradiological assessment at baseline and to perform speech/language treatment. Exclusion Criteria: - Orofacial structural abnormalities. - Known pathologies of neurological, neurometabolical and genetic etiologies. - Audiological deficits. - Epilepsy. - Intellectual disability. - Autism spectrum disorder.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
PROMPT- treatment
PROMPTs for Restructuring Oral Muscolar Phonetic Targets
LNSOM-treatment
Language Non-Speech Oral Motor Treatment

Locations

Country Name City State
Italy IRCCS Fondazione Stella Maris Marina di Pisa-Tirrenia-Calambrone Toscana

Sponsors (2)

Lead Sponsor Collaborator
IRCCS Fondazione Stella Maris Ministry of Health, Italy

Country where clinical trial is conducted

Italy, 

References & Publications (6)

Dale PS, Hayden DA. Treating speech subsystems in childhood apraxia of speech with tactual input: the PROMPT approach. Am J Speech Lang Pathol. 2013 Nov;22(4):644-61. doi: 10.1044/1058-0360(2013/12-0055). Epub 2013 Jun 28. — View Citation

Fiori S, Guzzetta A, Mitra J, Pannek K, Pasquariello R, Cipriani P, Tosetti M, Cioni G, Rose SE, Chilosi A. Neuroanatomical correlates of childhood apraxia of speech: A connectomic approach. Neuroimage Clin. 2016 Nov 4;12:894-901. doi: 10.1016/j.nicl.2016.11.003. eCollection 2016. — View Citation

Kadis DS, Goshulak D, Namasivayam A, Pukonen M, Kroll R, De Nil LF, Pang EW, Lerch JP. Cortical thickness in children receiving intensive therapy for idiopathic apraxia of speech. Brain Topogr. 2014 Mar;27(2):240-7. doi: 10.1007/s10548-013-0308-8. Epub 2013 Aug 24. — View Citation

Morgan AT, Su M, Reilly S, Conti-Ramsden G, Connelly A, Liegeois FJ. A Brain Marker for Developmental Speech Disorders. J Pediatr. 2018 Jul;198:234-239.e1. doi: 10.1016/j.jpeds.2018.02.043. Epub 2018 Apr 25. — View Citation

Namasivayam AK, Huynh A, Granata F, Law V, van Lieshout P. PROMPT intervention for children with severe speech motor delay: a randomized control trial. Pediatr Res. 2021 Feb;89(3):613-621. doi: 10.1038/s41390-020-0924-4. Epub 2020 May 1. — View Citation

Square PA, Namasivayam AK, Bose A, Goshulak D, Hayden D. Multi-sensory treatment for children with developmental motor speech disorders. Int J Lang Commun Disord. 2014 Sep-Oct;49(5):527-42. doi: 10.1111/1460-6984.12083. Epub 2014 Mar 12. No abstract available. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Speech Composite Severity Score changes after 7 months of treatment Speech Severity Score aggregates measures of DDK, inaccuracy, inconsistency, Phonetic inventory, Syllable Omissions. Score ranges form: 0 (normal) to 5 (severely impaired) At baselin and at 7 months of individual speech and language training
Secondary Post treatment Diffusion Weighed Imaging (DWI) metrics Fractional Anisotropy (FA) At baseline and at 7 months of speech and language training
Secondary Post treatment Diffusion Weighed Imaging (DWI) changes MD (Mean Diffusivity) At baseline and at 7 months of speech and language training
Secondary Post treatment cortical volumes modifications Cortical thickness At baseline and at 7 months of speech and language training
Secondary Post treatment cortical volumes changes Volumes analysis At baseline and at 7 months of speech and language training
See also
  Status Clinical Trial Phase
Recruiting NCT04642053 - A Randomized Control Trial of Motor-based Intervention for CAS N/A
Recruiting NCT05185583 - Methylphenidate in Childhood Apraxia of Speech Phase 2
Recruiting NCT05675306 - Dose Frequency RCT on DTTC in Children With CAS N/A
Recruiting NCT05916222 - The Effects of Caregiver Training on DTTC Treatment Outcomes in CAS N/A
Completed NCT03238677 - Treating Childhood Apraxia of Speech N/A
Recruiting NCT03903120 - ASSIST: Treatment for Childhood Apraxia of Speech Phase 1
Recruiting NCT06385470 - Treatment of Cantonese Speakers With Childhood Apraxia of Speech N/A